Filter
3721
Filtered Results: 3721
Text search:
essential
drug
list
Featured
Recommendations
389
New Publications
1079
Language
Document type
No document type
2225
Guidelines
542
Studies & Reports
512
Manuals
198
Strategic & Response Plan
126
Training Material
63
Fact sheets
28
Situation Updates
11
Brochures
7
Resource Platforms
4
Infographics
3
Online Courses
2
Countries / Regions
India
253
Kenya
125
Global
118
Ethiopia
103
South Africa
102
Uganda
90
Nigeria
83
Sierra Leone
75
Nepal
72
Liberia
69
Malawi
65
Tanzania
64
Western and Central Europe
59
Zambia
57
Ghana
54
Bangladesh
53
Latin America and the Carribbean
52
Myanmar / Burma
52
Africa
47
Namibia
37
Rwanda
34
Philippines
31
South–East Asia Region
26
Cambodia
25
Asia
24
Zimbabwe
23
Ukraine
22
Lesotho
22
Syria
21
Botswana
21
Eastern Europe
20
Burkina Faso
16
Mozambique
16
Eswatini/ Swaziland
16
Indonesia
15
Senegal
13
Congo, Democratic Republic of
13
Brazil
13
Haiti
12
Germany
11
USA
10
West and Central Africa
10
Thailand
9
Cameroon
9
Middle East and North Africa
9
Eastern Europe and Central Asia
9
East and Southern Africa
9
Russia
9
South Sudan
8
Afghanistan
7
Guinea
7
Venezuela
7
Pakistan
7
Laos
6
Western Pacific Region
6
Vietnam
6
Sudan
6
Benin
5
China
5
Albania
5
Paraguay
5
North America
5
Georgia
5
Iraq
5
Tajikistan
4
Mexico
4
Jordan
4
Central African Republic
4
North Macedonia
3
Colombia
3
Timor Leste/ East Timor
3
Chile
3
Fiji
3
Kyrgyzstan
3
Peru
3
Jamaica
3
United Kingdom
3
Argentina
3
Lebanon
3
Moldova
3
Yemen
3
Mali
3
Libya
3
Somalia
3
Kazakhstan
2
Iran
2
Canada
2
Morocco
2
Mongolia
2
Armenia
2
Guinea-Bissau
2
Hungary
2
Gabon
2
Uruguay
2
Bolivia
2
Papua New Guinea
2
Sri Lanka
2
Palestine
2
Angola
2
Bhutan
2
Madagascar
2
North Korea
1
El Salvador
1
Serbia
1
Turkey
1
Australia
1
Congo-Brazzaville
1
Niger
1
Qatar
1
Bulgaria
1
Saudi Arabia
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Portugal
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Nicaragua
1
Egypt
1
Greece
1
Poland
1
Honduras
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1525
Clinical Guidelines
374
Public Health
200
Women & Child Health
173
Key Resources
138
Capacity Building
58
Pharmacy & Technologies
57
Annual Report MEDBOX
1
Toolboxes
Mental Health
324
HIV
320
TB
307
AMR
219
Pharmacy
161
COVID-19
149
NTDs
118
Caregiver
100
Rapid Response
83
NCDs
75
Ebola & Marburg
57
Conflict
51
Planetary Health
44
Refugee
42
Disability
42
Global Health Education
39
Health Financing Toolbox
24
Specific Hazards
16
Polio
16
Natural Hazards
15
Cholera
14
Social Ethics
12
Malaria
10
Zika
5
The publication of the Second Edition of the Emergency Drug Guidelines represents the culmination of the efforts of the National Drugs and Therapeutics Committee (NDTC) to publish clinical drug guidelines for common diseases seen in Fiji. These guidelines are targeted for health care professionals w...
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List ...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo...
CHAPTER 206 | An Act to establish a national drug policy and a national drug authority to ensure the availability, at all times, of essential, efficacious and cost-effective drugs to the entire population of Uganda, as a means of providing satisfactory health care and safeguarding the appropriate us...
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ...
WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essential Medicines and Health Products Price and Availability Monitoring Mobile Application. This tool fac...
The Federal Ministry of Health (FMOH) has been coordinating sector wide reforms that aim to improve equity and quality of health services. It is widely known that; the sector is growing in line the overall growth and transformation plan of the country and the sector is bein...
MSF Essential Drugs - Practical Guidelines 2022
recommended
Practical guide intended for physicians, pharmacists, nurses and medical auxiliaries. This guide is not a dictionary of pharmacological agents. It is a practical manual intended for health professionals, physicians, pharmacists, nurses and health auxiliaries invoved in curative care and drug managem...
The document is structured into five sections. The first presents the key experiences and challenges that justify a renewal of the EPHFs. The second section updates the groundwork for the exercise of public health and provides a framework to inform the exercise of the new essential functions. The th...
For the first time in almost 50 years there are two new drugs for the treatment of drug-resistant TB (DR-TB): bedaquiline and delamanid. There has also been increased attention given to the safety and efficacy of “re-purposed” drugs that have been widely used to treat other infections but are al...
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner drug ...
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Incorporating Malawi Essential Medicines List (MEML)
WHO Model Formulary for Children
recommended
WHO Model Formulary for children based on the Second Model List of Essential Medicines for Children 2009.
In 2007, the World Health Assembly passed a Resolution titled ‘Better Medicines for Children’. This resolution recognized the need for research and development into medicines for children,...
The WHO CIA List should be used as a reference to help formulate and prioritize risk assessment and risk management strategies for containing antimicrobial resistance. The WHO CIA List supports strategies to mitigate the human health risks associated with antimicrobial use in ...
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was...
Millennium Development Goal 8E aims for affordable access to essential medicines. Essential medicines, as defined by WHO, are those that “satisfy the health-care needs of the majority of the population” and that should therefore “be available at all times in adequate amounts”. However, there...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
